Product

Pregabalin 450 mg + Oxycodone 20 mg

1 clinical trial

1 indication

Indication

Abuse Potential

Clinical trial

A Phase 4 Randomized Double-Blind Double-Dummy Placebo & Active-Controlled Single-Dose Six-Way Crossover Study Evaluating the Abuse Potential of Lyrica® Taken Orally With Oxycodone HCL in Healthy Non-Drug Dependent Recreational Opioid Users

Status: Completed, Estimated PCD: 2022-04-01